A detailed history of Allianz Asset Management Gmb H transactions in Zai Lab LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 521,825 shares of ZLAB stock, worth $15.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
521,825
Previous 521,825 -0.0%
Holding current value
$15.1 Million
Previous $9.04 Million 39.29%
% of portfolio
0.02%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$13.72 - $21.55 $2.77 Million - $4.35 Million
-202,021 Reduced 27.91%
521,825 $9.04 Million
Q1 2024

May 13, 2024

BUY
$15.95 - $26.8 $706,935 - $1.19 Million
44,322 Added 6.52%
723,846 $11.6 Million
Q4 2023

Feb 12, 2024

BUY
$22.97 - $30.58 $3.23 Million - $4.3 Million
140,461 Added 26.06%
679,524 $18.6 Million
Q3 2023

Nov 13, 2023

BUY
$22.72 - $31.49 $1.48 Million - $2.05 Million
65,072 Added 13.73%
539,063 $13.1 Million
Q2 2023

Aug 11, 2023

BUY
$25.3 - $39.67 $3.63 Million - $5.69 Million
143,319 Added 43.34%
473,991 $13.1 Million
Q1 2023

May 11, 2023

BUY
$30.21 - $48.1 $504,114 - $802,644
16,687 Added 5.31%
330,672 $11 Million
Q4 2022

Feb 13, 2023

BUY
$22.28 - $38.71 $2.13 Million - $3.7 Million
95,500 Added 43.71%
313,985 $9.64 Million
Q3 2022

Nov 08, 2022

SELL
$34.2 - $51.69 $1.65 Million - $2.49 Million
-48,103 Reduced 18.04%
218,485 $7.47 Million
Q2 2022

Aug 12, 2022

SELL
$23.14 - $49.68 $11,801 - $25,336
-510 Reduced 0.19%
266,588 $9.25 Million
Q1 2022

May 13, 2022

SELL
$27.77 - $64.4 $772,950 - $1.79 Million
-27,834 Reduced 9.44%
267,098 $11.7 Million
Q4 2021

Feb 11, 2022

SELL
$54.9 - $105.21 $4.7 Million - $9 Million
-85,576 Reduced 22.49%
294,932 $18.5 Million
Q3 2021

Nov 10, 2021

SELL
$105.0 - $178.37 $1.18 Million - $2 Million
-11,206 Reduced 2.86%
380,508 $40.1 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $23.2 Million - $33.3 Million
185,252 Added 89.73%
391,714 $69.3 Million
Q1 2021

May 13, 2021

BUY
$126.27 - $191.71 $15.1 Million - $22.9 Million
119,606 Added 137.71%
206,462 $27.5 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $3.26 Million - $5.38 Million
39,781 Added 84.51%
86,856 $11.8 Million
Q3 2020

Nov 13, 2020

SELL
$73.3 - $89.48 $3.07 Million - $3.75 Million
-41,890 Reduced 47.09%
47,075 $3.92 Million
Q2 2020

Aug 14, 2020

SELL
$48.82 - $82.53 $4.94 Million - $8.36 Million
-101,240 Reduced 53.23%
88,965 $7.31 Million
Q1 2020

May 14, 2020

SELL
$39.1 - $62.9 $1.09 Million - $1.75 Million
-27,795 Reduced 12.75%
190,205 $9.79 Million
Q4 2019

Feb 13, 2020

BUY
$29.79 - $43.06 $2.71 Million - $3.92 Million
91,075 Added 71.75%
218,000 $9.07 Million
Q3 2019

Nov 13, 2019

BUY
$30.47 - $37.65 $512,505 - $633,273
16,820 Added 15.28%
126,925 $4.11 Million
Q2 2019

Aug 08, 2019

BUY
$25.73 - $35.79 $2.83 Million - $3.94 Million
110,105 New
110,105 $3.84 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.82B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.